Form 4: Third Harmonic Bio Executive Jennifer Dittman Exercises Options and Sells Shares

Jennifer Dittman, Chief Development Operations Officer at Third Harmonic Bio, exercised stock options and sold shares on May 16, 2024, according to a Form 4 filing with the SEC.

Summary

• On May 16, 2024, Jennifer Dittman, Chief Development Operations Officer of Third Harmonic Bio, exercised employee stock options to acquire 16,666 shares at $4.30 and 6,912 shares at $4.20.
• She also acquired 100,000 shares through an employee stock option with an exercise price of $14.23.
• Dittman sold 23,578 shares of common stock at a weighted average price of $14.0413, with individual sales ranging from $14.00 to $14.0778 per share.
• Following these transactions, Dittman directly owns no shares, but beneficially owns 33,334 shares through employee stock options with an exercise price of $4.30, 16,788 shares through employee stock options with an exercise price of $4.20, and 100,000 shares through employee stock options with an exercise price of $14.23.
• The sale was executed under a pre-arranged Rule 10b5-1 trading plan adopted on March 27, 2024.

Sentiment

Score: 5

Explanation: The document is a standard SEC filing related to executive stock transactions, which is neutral in sentiment. It reflects routine activity rather than a significant event impacting the company's outlook.

Industry Context

Executive stock transactions are a common occurrence in publicly traded companies, and are closely watched by investors as they can provide insights into management's perspective on the company's value and future prospects. The use of 10b5-1 trading plans is a standard practice to avoid accusations of insider trading.

Comparison to Industry Standards

• Executive compensation packages, including stock options, are common across the biotechnology industry.
• Companies like Amgen, Biogen, and Gilead Sciences also utilize stock options as part of their executive compensation plans.
• The vesting schedules and exercise prices are generally aligned with industry norms to incentivize long-term performance.

Stakeholder Impact

• The sale of shares by an executive could be perceived negatively by some shareholders, although the existence of a pre-arranged trading plan mitigates this concern.
• The exercise of stock options dilutes existing shareholders' equity to a small degree.

Key Dates